-
Centre of
Excellence
Centre of Excellence
Other Specialities
- Allergy and Immunology
- Andrology
- Anesthesiology
- Dental Medicine
- Dermatology
- Diabetes and Endocrinology
- Ear Nose Throat
- Electrophysiology
- Fetal Medicine
- General Medicine
- General Surgery
- Geriatric Medicine
- GI Surgery
- Growth and Hormone
- Gynaec Oncology
- Hand Surgery
- Hemato Oncology
- Hematology
- Hepatobiliary Surgery
- ICU and Critical Care
- Infectious Disease
- Internal Medicine
- Interventional Radiology
- Kidney Transplant
- Lifestyle Clinic
- Medical Gastro
- Medical Oncology
- Microbiology
- Minimal Access Surgery
- Neonatology & NICU
- Nuclear Medicine
- Nutrition And Dietetics
- Ophthalmology
- Oral Maxillo Facial Surgery
- Paediatric Urology
- Pain Medicine
- Parkinson Disease and Movement Disorder
- Pathology
- Pharmacy
- Physiotherapy
- Plastic And Cosmetic Surgery
- Psychiatry
- Pulmonology (Respiratory and Sleep Medicine)
- Radiology
- Radiotherapy (Oncology Radiation)
- Renal Sciences
- Surgical Gastro
- Surgical Oncology
- Transfusion Medicine
- Vascular and Endovascular Surgery
Speciality Clinics
- Doctors
- Dhakuria
- International Patients
Clinics
Search- Self Registration
- Mars - Ambulance
- Corporate & PSU
- Insurance Helpdesk
- Awards And Achievements
- Careers
- Contact Us
PICK A TIME SLOT
₹ Price not available
Dhakuria - Kolkata
Schedule Your Appointment Today
Doctor Consultation Charges (Hospital Visit)- Price not Available
Doctor Consultation Charges (Video Consultation) - Rs. Price not Available/-
After you have submitted the appointment request, we might call to confirm the preferred appointment slot.
Doctor Consultation Charges (Video Consultation) - Rs. Price not Available/-
Confirm Appointment
You will receive an SMS with a verification code on this number.
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP click resend option
Your appointment is confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Confirm Appointment
Your Appointment will be confirmed after generating Pre Registration ID and making payment for consultation now.
Patient Registration Details
1
Basic Details
Other Details
Declaration
Patient Registration Details
Basic Details
2
Other Details
Declaration
Patient Registration Details
Basic Details
Other Details
3
Declaration
Consent and Declaration
I, the undersigned, declare that the above information provided by me are true to the best of my knowledge and hereby provide my consent to the Manipal Hospital to provide Medical Care, Treatment, Conduct Investigations and Diagnostic Procedures necessary for the above mentioned individual by Medical Staff at Manipal Hospital. I, also understand that Manipal Hospital will not be responsible for any loss, damage or theft of any Personal Property/Belongings of Me/Patient/Visitors within the Hospital Premises. Including Patients rooms and Parking area. I agree to follow all the rules and regulations of Hospital and clear all the expenses incurred for My/Patient treatment on time as per the Terms and Conditions of Manipal Hospital,
If consent provided on behalf of the patient.
I hereby give my consent and authorize Manipal Hospitals to process, store,use,disclose my personal or sensitive information/data collected as per Manipal Privacy Policy
We have sent you an OTP on
Resend OTP
Did not receive an OTP? You Can Request For Another OTP Click Resend Option
Patient Details
ALREADY APPOINTMENT IS AVAILABLE FOR THIS PATIENT
SOMETHING WENT WRONG! PLEASE TRY AGAIN IN SOMETIME.
We see that your email address is not updated in our system. Hence, we couldn't able to complete this transaction.We request you to call our appointment helpline number: 033 6907 0001 to book an appointment.
The Mobile Number entered is not registered with Manipal Hospitals.
To continue, re-enter your Registered Mobile Number or Generate Pre Registration ID and make payment for the Doctor Appointment.
The entered UHID Number is not registered with Manipal Hospitals.
To continue, re-enter your Register or Generate Pre Registration ID and make payment for the Doctor Appointment.
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Amit Dutt Dwary is a consultant in the Department of Medical Oncology at Manipal Hospital Dhakuria, Kolkata. With an academic background of MBBS, MD (General Medicine) and DM (Medical Oncology), followed by dedicated training and research, Dr. Amit Dutt Dwary offers comprehensive cancer treatment using modern medical interventions.
Over the course of his 18+ years of practice, Dr. Amit Dutt Dwary has remained associated with reputed medical institutions, including Apollo Gleneagles Hospital and Tata Medical Centre, where he served as a consultant for patients and specialised in the treatment of various subspecialties of cancer. He specialises in providing treatments like chemotherapy, targeted therapy and immunotherapy for a broad range of cancers, including lung cancer, breast cancer, CNS malignancies, haematological cancers, actinic keratosis and cholangiocarcinoma.
Beyond his clinical practice, Dr. Amit Dutt Drawy is committed towards remaining at the forefront of medical advancements through his various research works and publications. His impressive academic prowess can be attributed to his winning a gold medal in Pharmacology, as well as a gold medal for Best Post Graduate in Oncology. With an approach rooted in compassion and patient-centricity, Dr. Amit Dutt Dwary is a trusted name among those seeking advanced cancer care.
- Lung Cancer
- Breast Cancer
- Head and Neck Cancers
- Gynecological Malignancies
- GI Tract Cancers
- CNS Tumours
- Haematological Malignancies
- English
- Bengali
- Hindi
- A randomised controlled trial comparing best supportive care, 5-FU plus folinic acid and Gemcitabine plus Oxaliplatin in the management of unresectable gallbladder cancer (Journal of Clinical Oncology, Sep 20, 2010).
- A randomized double blind phase III study of efficacy of Lactobacillus CD2 lozenges in preventing radiation- and chemotherapy-induced oral mucositis in head and neck cancer patients. (Journal of Clinical Oncology, vol 27, no 15S, part I, May, 2009).
- A phase II study of gemcitabine and oxaliplatin (Oxygem) in unresectable gallbladder cancer. (Cancer Chemother Pharmacol, july, 2009).
- Non-Hodgkin's lymphoma following temozolomide. (Pediatric Blood Cancer, 16 Jun, 2009).
- Hodgkin lymphoma involving ascending colon and mesenteric lymph node: a rare entity. (Indian Journal of Cancer 2009, April-June; 46: 176-6).
- Pathological complete response following Gem-Ox chemotherapy in unresectable gallbladder cancer. (Accepted for publication in Tropical Gastroenterology).
- Choledochal cyst with Obstructive Jaundice Mimiking abdominal Burkitt's lymphoma. (Pediatr Blood Cancer. 2008 May;50(5):1080-1).
- Review article: adjuvant chemotherapy for gallbladder cancer (Indian Journal of Pediatric and Medical Oncology, September 2006.
- ROS-1 crizotinib –experience from Indian Subcontinent — IJC 2017.
- Ceritinib in AKLK-positive NSCLC — IJC 2017.
- Non-HDMTX regimen in osteosarcoma – European Journal of Cancer 2017.
- Nivolumab in lung cancer – IJC 2017.
Overview
Field of Expertise
Languages Spoken
Talks & Publications
- English
- Bengali
- Hindi
Dr. Amit Dutt Dwary is a consultant in the Department of Medical Oncology at Manipal Hospital Dhakuria, Kolkata. With an academic background of MBBS, MD (General Medicine) and DM (Medical Oncology), followed by dedicated training and research, Dr. Amit Dutt Dwary offers comprehensive cancer treatment using modern medical interventions.
Over the course of his 18+ years of practice, Dr. Amit Dutt Dwary has remained associated with reputed medical institutions, including Apollo Gleneagles Hospital and Tata Medical Centre, where he served as a consultant for patients and specialised in the treatment of various subspecialties of cancer. He specialises in providing treatments like chemotherapy, targeted therapy and immunotherapy for a broad range of cancers, including lung cancer, breast cancer, CNS malignancies, haematological cancers, actinic keratosis and cholangiocarcinoma.
Beyond his clinical practice, Dr. Amit Dutt Drawy is committed towards remaining at the forefront of medical advancements through his various research works and publications. His impressive academic prowess can be attributed to his winning a gold medal in Pharmacology, as well as a gold medal for Best Post Graduate in Oncology. With an approach rooted in compassion and patient-centricity, Dr. Amit Dutt Dwary is a trusted name among those seeking advanced cancer care.
- Lung Cancer
- Breast Cancer
- Head and Neck Cancers
- Gynecological Malignancies
- GI Tract Cancers
- CNS Tumours
- Haematological Malignancies
- A randomised controlled trial comparing best supportive care, 5-FU plus folinic acid and Gemcitabine plus Oxaliplatin in the management of unresectable gallbladder cancer (Journal of Clinical Oncology, Sep 20, 2010).
- A randomized double blind phase III study of efficacy of Lactobacillus CD2 lozenges in preventing radiation- and chemotherapy-induced oral mucositis in head and neck cancer patients. (Journal of Clinical Oncology, vol 27, no 15S, part I, May, 2009).
- A phase II study of gemcitabine and oxaliplatin (Oxygem) in unresectable gallbladder cancer. (Cancer Chemother Pharmacol, july, 2009).
- Non-Hodgkin's lymphoma following temozolomide. (Pediatric Blood Cancer, 16 Jun, 2009).
- Hodgkin lymphoma involving ascending colon and mesenteric lymph node: a rare entity. (Indian Journal of Cancer 2009, April-June; 46: 176-6).
- Pathological complete response following Gem-Ox chemotherapy in unresectable gallbladder cancer. (Accepted for publication in Tropical Gastroenterology).
- Choledochal cyst with Obstructive Jaundice Mimiking abdominal Burkitt's lymphoma. (Pediatr Blood Cancer. 2008 May;50(5):1080-1).
- Review article: adjuvant chemotherapy for gallbladder cancer (Indian Journal of Pediatric and Medical Oncology, September 2006.
- ROS-1 crizotinib –experience from Indian Subcontinent — IJC 2017.
- Ceritinib in AKLK-positive NSCLC — IJC 2017.
- Non-HDMTX regimen in osteosarcoma – European Journal of Cancer 2017.
- Nivolumab in lung cancer – IJC 2017.
Languages Spoken
Overview
Field of Expertise
Talks & Publications
- Lung Cancer
- Breast Cancer
- Head and Neck Cancers
- Gynecological Malignancies
- GI Tract Cancers
- CNS Tumours
- Haematological Malignancies
- English
- Bengali
- Hindi
- A randomised controlled trial comparing best supportive care, 5-FU plus folinic acid and Gemcitabine plus Oxaliplatin in the management of unresectable gallbladder cancer (Journal of Clinical Oncology, Sep 20, 2010).
- A randomized double blind phase III study of efficacy of Lactobacillus CD2 lozenges in preventing radiation- and chemotherapy-induced oral mucositis in head and neck cancer patients. (Journal of Clinical Oncology, vol 27, no 15S, part I, May, 2009).
- A phase II study of gemcitabine and oxaliplatin (Oxygem) in unresectable gallbladder cancer. (Cancer Chemother Pharmacol, july, 2009).
- Non-Hodgkin's lymphoma following temozolomide. (Pediatric Blood Cancer, 16 Jun, 2009).
- Hodgkin lymphoma involving ascending colon and mesenteric lymph node: a rare entity. (Indian Journal of Cancer 2009, April-June; 46: 176-6).
- Pathological complete response following Gem-Ox chemotherapy in unresectable gallbladder cancer. (Accepted for publication in Tropical Gastroenterology).
- Choledochal cyst with Obstructive Jaundice Mimiking abdominal Burkitt's lymphoma. (Pediatr Blood Cancer. 2008 May;50(5):1080-1).
- Review article: adjuvant chemotherapy for gallbladder cancer (Indian Journal of Pediatric and Medical Oncology, September 2006.
- ROS-1 crizotinib –experience from Indian Subcontinent — IJC 2017.
- Ceritinib in AKLK-positive NSCLC — IJC 2017.
- Non-HDMTX regimen in osteosarcoma – European Journal of Cancer 2017.
- Nivolumab in lung cancer – IJC 2017.
Dr. Amit Dutt Dwary is a consultant in the Department of Medical Oncology at Manipal Hospital Dhakuria, Kolkata. With an academic background of MBBS, MD (General Medicine) and DM (Medical Oncology), followed by dedicated training and research, Dr. Amit Dutt Dwary offers comprehensive cancer treatment using modern medical interventions.
Over the course of his 18+ years of practice, Dr. Amit Dutt Dwary has remained associated with reputed medical institutions, including Apollo Gleneagles Hospital and Tata Medical Centre, where he served as a consultant for patients and specialised in the treatment of various subspecialties of cancer. He specialises in providing treatments like chemotherapy, targeted therapy and immunotherapy for a broad range of cancers, including lung cancer, breast cancer, CNS malignancies, haematological cancers, actinic keratosis and cholangiocarcinoma.
Beyond his clinical practice, Dr. Amit Dutt Drawy is committed towards remaining at the forefront of medical advancements through his various research works and publications. His impressive academic prowess can be attributed to his winning a gold medal in Pharmacology, as well as a gold medal for Best Post Graduate in Oncology. With an approach rooted in compassion and patient-centricity, Dr. Amit Dutt Dwary is a trusted name among those seeking advanced cancer care.
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- A randomised controlled trial comparing best supportive care, 5-FU plus folinic acid and Gemcitabine plus Oxaliplatin in the management of unresectable gallbladder cancer (Journal of Clinical Oncology, Sep 20, 2010).
- A randomized double blind phase III study of efficacy of Lactobacillus CD2 lozenges in preventing radiation- and chemotherapy-induced oral mucositis in head and neck cancer patients. (Journal of Clinical Oncology, vol 27, no 15S, part I, May, 2009).
- A phase II study of gemcitabine and oxaliplatin (Oxygem) in unresectable gallbladder cancer. (Cancer Chemother Pharmacol, july, 2009).
- Non-Hodgkin's lymphoma following temozolomide. (Pediatric Blood Cancer, 16 Jun, 2009).
- Hodgkin lymphoma involving ascending colon and mesenteric lymph node: a rare entity. (Indian Journal of Cancer 2009, April-June; 46: 176-6).
- Pathological complete response following Gem-Ox chemotherapy in unresectable gallbladder cancer. (Accepted for publication in Tropical Gastroenterology).
- Choledochal cyst with Obstructive Jaundice Mimiking abdominal Burkitt's lymphoma. (Pediatr Blood Cancer. 2008 May;50(5):1080-1).
- Review article: adjuvant chemotherapy for gallbladder cancer (Indian Journal of Pediatric and Medical Oncology, September 2006.
- ROS-1 crizotinib –experience from Indian Subcontinent — IJC 2017.
- Ceritinib in AKLK-positive NSCLC — IJC 2017.
- Non-HDMTX regimen in osteosarcoma – European Journal of Cancer 2017.
- Nivolumab in lung cancer – IJC 2017.
Dr. Amit Dutt Dwary is a consultant in the Department of Medical Oncology at Manipal Hospital Dhakuria, Kolkata. With an academic background of MBBS, MD (General Medicine) and DM (Medical Oncology), followed by dedicated training and research, Dr. Amit Dutt Dwary offers comprehensive cancer treatment using modern medical interventions.
Over the course of his 18+ years of practice, Dr. Amit Dutt Dwary has remained associated with reputed medical institutions, including Apollo Gleneagles Hospital and Tata Medical Centre, where he served as a consultant for patients and specialised in the treatment of various subspecialties of cancer. He specialises in providing treatments like chemotherapy, targeted therapy and immunotherapy for a broad range of cancers, including lung cancer, breast cancer, CNS malignancies, haematological cancers, actinic keratosis and cholangiocarcinoma.
Beyond his clinical practice, Dr. Amit Dutt Drawy is committed towards remaining at the forefront of medical advancements through his various research works and publications. His impressive academic prowess can be attributed to his winning a gold medal in Pharmacology, as well as a gold medal for Best Post Graduate in Oncology. With an approach rooted in compassion and patient-centricity, Dr. Amit Dutt Dwary is a trusted name among those seeking advanced cancer care.
- Lung Cancer
- Breast Cancer
- Head and Neck Cancers
- Gynecological Malignancies
- GI Tract Cancers
- CNS Tumours
- Haematological Malignancies
- English
- Bengali
- Hindi
Talks & Publications
Overview
Field of Expertise
Languages Spoken
The benefits of Prime Access OPS are as below:
- Minimal Waiting Time for Consultations.
- Exclusive Waiting Area
- Personal Attention.
- Fast tracked Services.
FAQ's
Patients visit Dr. Amit Dutt Dwary, a leading Consultant - Medical Oncology at Manipal Hospitals Dhakuria - Kolkata, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Amit Dutt Dwary is a trusted choice for exceptional medical support.
Dr. Amit Dutt Dwary Specialises in:
- Lung Cancer
- Breast Cancer
- Head and Neck Cancers
- Gynecological Malignancies
- GI Tract Cancers
- CNS Tumours
- Haematological Malignancies
To book an appointment with Dr. Amit Dutt Dwary at Manipal Hospitals Dhakuria - Kolkata, please call 033 6907 0001 / 033 6907 0000. Our dedicated team will assist you in scheduling a convenient time for your consultation.
Dr. Amit Dutt Dwary has extensive experience and qualifications in Medical Oncology at Manipal Hospitals Dhakuria - Kolkata. With expertise spanning MBBS . MD (General Medicine) . DM (Medical Oncology), bringing a wealth of knowledge and skill to their practice, ensuring top-notch patient care. Dr. Amit Dutt Dwary has also published numerous articles and publications in the field of Medical Oncology.
For your initial appointment with Dr. Amit Dutt Dwary, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents. This will help facilitate a comprehensive evaluation and discussion during your appointment.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
You’re on Our Indian Website
Visit the Global site for International patient services
Your Feedback is Highly Valued!
'Click' to chat with us
